There is a growing demand for ingredients and nutritional products in the market today as consumers seek to maintain their health. Supplements that address digestive health and immune function are just two of the top priorities, especially in China, as there is a growing need for human probiotics.
To meet the Chinese market, SMA will partner with Qingdao Vland Biotech Group Co. Ltd, producer of enzymes and probiotics. This joint venture, scheduled for launch in the first half of 2022, will bring the expertise and experience of both companies to introduce innovative solutions in the field of intestinal health.
“This exciting new joint venture represents the latest expansion of our large-scale global health and wellness business, which helps propel the growth of our entire human and animal nutrition portfolio and creates value for ADM and its customers, ”said Vince Macciocchi, president of ADM’s Nutrition business. “We are excited to partner with Vland to help meet the needs of consumers who are increasingly aware of the strong connection between gut microbiome health and their overall health. The retail demand for probiotics in China is estimated at $ 1 billion in 2022, with annual growth of over 9%, and we believe this new venture, fueled by the expertise and experience of ADM and Vland, is perfectly positioned to play a leading role. role to meet this demand.
“Vland is delighted to partner with ADM to explore the promising human probiotics market,” said Aron Chen, CEO of Vland. “We believe that this strong partnership between Vland and ADM – fueled by technology, brand and sales channels from both parties – will be perfectly positioned to expand production and meet the demand for high quality human probiotics in China and for global customers. “
